[ET Net News Agency, 13 March 2025] GRAND PHARMA (00512) rose 21.2% to HK$6.35.
It hits an intra-day high of HK$6.35, hitting a 52-week high, and an intra-day low of
HK$5.46. The total shares traded was 67.2 million, with a value of HK$400.09m. The active
buy/sell ratio is 67:33, with net buying turnover of HK$129.6m. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$9.17m, with volume weighted
average price of HK$5.945. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$19.56m, with volume weighted average price of HK$5.956.

Basic Information
=================

---------------------------------
Nominal 6.350 % Chg +21.18%
High 6.350 Low 5.460
Shares Tr 67.2m Turnover 400.09m
10-D SMA 5.322 %H.V 35.172
20-D SMA 5.069 VWAP 5.954
50-D SMA 4.684 RSI14 81.875
---------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 67:33, with net buying turnover
of HK$129.6m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
GRAND PHARMA (00512) 6.35 +21.18
SIHUAN PHARM (00460) 0.59 -1.67
SINO BIOPHARM (01177) 3.48 -1.42
LIVZON PHARMA (01513) 26.05 +1.36
LUYE PHARMA (02186) 2.31 -0.43
FOSUN PHARMA (02196) 14.88 -1.59
SH PHARMA (02607) 11.72 -1.01
CHINARES PHARMA (03320) 5.40 +2.08
HANSOH PHARMA (03692) 18.76 -0.21
ZHAOKE OPHTH-B (06622) 1.95 -2.01
-----------------------------------------------
(ed)